FARADEX

SECTION 2: Hazards identification

OSHA The additives in this product are bound in a thermoplastic resin matrix. In accordance with GHS for the classification of the product, the hazard potential may be assessed with respect to the physico-chemical form and/or bioavailability of the individual components in the thermoplastic resin. Where GHS classifications are shown below, these are based on the individual components in the thermoplastic resin matrix. Under the typical use conditions for the resin, these hazardous components are unlikely to contribute to workplace exposure. Please read the entire safety data sheet and/or consult an EHS professional for a complete understanding. Classification

2.2 Label elements

Emergency Overview Not classified The product contains no substances which at their given concentration, are considered to be hazardous to health Appearance: Pellets Physical State: Solid Odor: None or slight

2.3 Other hazards

Not applicable

Further information

Not applicable

Other hazards which do not result in classification

SABIC Emergency Overview • Pellets with slight or no odor • Spilled material may create slipping hazard • Can burn in a fire creating dense, toxic smoke • Molten plastic can cause severe thermal burns • Fumes produced during melt processing may cause eye, skin, and respiratory tract irritation. Severe over-exposure may result in nausea, headache, chills, and fever. See below for additional effects. • Secondary operations, such as grinding, sanding, or sawing can produce dust which may present an explosion or respiratory hazard.

Medical Conditions Generally Aggravated by Exposure

MEDICAL RESTRICTIONS: There are no known health effects aggravated by exposure to this product. However, certain sensitive individuals and individuals with respiratory impairments may be affected by exposure to components in the processing vapors.

2.1 Classification of the substance or mixture

OSHA Regulatory Status This product is not considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200) In 1995, the International Agency for Research on Cancer (IARC) concluded that there is "sufficient evidence in experimental animals for the carcinogenicity of carbon black." IARC's overall evaluation was that "Carbon black is possibly carcinogenic to humans (2B)." In 2006, IARC re-affirmed this classification. There has been no causal link between carbon black exposure and cancer risk in humans. Applying the rules of the Globally Harmonized System of Classification and Labelling (GHS, e.g. UN `Purple Book´, EU CLP Regulation) the results of repeated dose toxicity and carcinogenicity studies in animals do not lead to classification of Carbon Black for Specific Target Organ Toxicity (Repeated exposure) and carcinogenicity. UN GHS says, that even if adverse effects are seen in animal studies or in-vitro tests, no classification is needed if the mechanism or mode of action is not relevant to humans. The European CLP Regulation also mentions, that no classification is indicated if the mechanism is not relevant to humans. Furthermore, the CLP guidance on classification and labelling states, that “lung overload“ in animals is listed under mechanism not relevant to humans.